Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ole Haagen Nielsen, Jakob Benedict Seidelin, Mark Ainsworth & Mehmet Coskun. (2016) Will novel oral formulations change the management of inflammatory bowel disease?. Expert Opinion on Investigational Drugs 25:6, pages 709-718.
Read now
Read now
Articles from other publishers (15)
Darren FinkelsteinTimothy D. Machajewski. 2023. 2023 Medicinal Chemistry Reviews. 2023 Medicinal Chemistry Reviews
187
207
.
Clara Abraham, Maria T. Abreu & Jerrold R. Turner. (2022) Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease. Gastroenterology 162:6, pages 1602-1616.e6.
Crossref
Crossref
Max Van Hoof, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen & Steven De Jonghe. (2022) Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine. European Journal of Medicinal Chemistry 235, pages 114268.
Crossref
Crossref
Yuki Hayashi & Hiroshi Nakase. (2022) The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease. Frontiers in Physiology 13.
Crossref
Crossref
Galal H. Elgemeie, Rasha A. Azzam, Wafaa A. Zaghary, Ashraf A. Aly, Nadia H. Metwally, Mona O. Sarhan, Elshimaa M. Abdelhafez & Rasha E. Elsayed. 2022. N-Sulfonated-N-Heterocycles. N-Sulfonated-N-Heterocycles
447
496
.
Sean Liu, Uyen Ngo, Xin-Zi Tang, Xin Ren, Wenli Qiu, Xiaozhu Huang, William DeGrado, Christopher D.C. Allen, Hyunil Jo, Dean Sheppard & Aparna B. Sundaram. (2021) Integrin α2β1 regulates collagen I tethering to modulate hyperresponsiveness in reactive airway disease models. Journal of Clinical Investigation 131:12.
Crossref
Crossref
Wai Po Chong, Mary J. Mattapallil, Kumarkrishna Raychaudhuri, So Jin Bing, Sihan Wu, Yajie Zhong, WeiWei Wang, Zilin Chen, Phyllis B. Silver, Yingyos Jittayasothorn, Chi-Chao Chan, Jun Chen, Reiko Horai & Rachel R. Caspi. (2020) The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24. Immunity 53:2, pages 384-397.e5.
Crossref
Crossref
Cheng Zhao, Xiaoming Kao, Zhiwei Wang, Qinjie Liu, Jie Wu, Qiongyuan Hu, Xiuwen Wu & Jianan Ren. (2020) Biomimetic enzyme barrier for preventing intestine-derived LPS induced diseases. RSC Advances 10:15, pages 9126-9132.
Crossref
Crossref
Philip Mease, Euthalia Roussou, Gerd-Rüdiger Burmester, Philippe Goupille, Alice Gottlieb, Susan R. Moriarty, Olivier Benichou, David H. Adams, Wen Xu & Peter Nash. (2019) Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials. Arthritis Care & Research 71:3, pages 367-378.
Crossref
Crossref
Luca Di Martino, Abdullah Osme, Sarah Kossak-Gupta, Theresa T. Pizarro & Fabio Cominelli. (2019) TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Cellular and Molecular Gastroenterology and Hepatology 8:3, pages 427-446.
Crossref
Crossref
Anthony So & Robert Davies Inman. (2018) An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis. Best Practice & Research Clinical Rheumatology 32:3, pages 453-471.
Crossref
Crossref
Sahil Sekhon, Caleb Jeon & Wilson Liao. 2018. Evidence-Based Psoriasis. Evidence-Based Psoriasis
73
92
.
Bruce Strober, Craig Leonardi, Kim A. Papp, Ulrich Mrowietz, Mamitaro Ohtsuki, Robert Bissonnette, Laura K. Ferris, Carle Paul, Mark Lebwohl, Daniel K. Braun, Lotus Mallbris, Stefan Wilhelm, Wen Xu, Anders Ljungberg, Nayan Acharya & Kristian Reich. (2017) Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data. Journal of the American Academy of Dermatology 76:3, pages 432-440.e17.
Crossref
Crossref
Clara Abraham, Parambir S. Dulai, Séverine Vermeire & William J. Sandborn. (2017) Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases. Gastroenterology 152:2, pages 374-388.e4.
Crossref
Crossref
Dhavalkumar D. Patel & Vijay K. Kuchroo. (2015) Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. Immunity 43:6, pages 1040-1051.
Crossref
Crossref